Vimarsana
Biggest News Aggregation in the World

Page 12 - Diagnostics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Inc Today - Breaking & Trending Today

Southern District Of New York Declines To Dismiss Claims In Putative Class Action Against Medical Test Manufacturer - Corporate and Company Law - Vimarsana News

Southern District Of New York Declines To Dismiss Claims In Putative Class Action Against Medical Test Manufacturer - Corporate and Company Law

On February 5, 2024, Judge Arun Subramanian of the United States District Court for the Southern District of New York largely declined to dismiss a putative class action asserting claims under the Securities Exchange Act of 1934 ...

Source: mondaq.com
Southern District Of New York Declines To Dismiss Claims In Putative Class Action Against Medical Test Manufacturer - Vimarsana News

Southern District Of New York Declines To Dismiss Claims In Putative Class Action Against Medical Test Manufacturer

On February 5, 2024, Judge Arun Subramanian of the United States District Court for the Southern District of New York largely declined to dismiss a putative class action asserting claims under the...

Lucid Diagnostics Inc. (NASDAQ:LUCD) Sees Significant Growth in Short Interest - Vimarsana News

Lucid Diagnostics Inc. (NASDAQ:LUCD) Sees Significant Growth in Short Interest

Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Free Report) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 126,600 shares, an increase of 16.4% from the January 15th total of 108,800 shares. Currently, 1.8% of the company’s stock are short sold. Based on an average trading volume […]

Radiopharmaceuticals Market Targets US$ 9.5 Billion Milestone by 2032, Accelerating Growth in Nuclea - Vimarsana News

Radiopharmaceuticals Market Targets US$ 9.5 Billion Milestone by 2032, Accelerating Growth in Nuclea

Radiopharmaceuticals MarketThe Radiopharmaceuticals Market has experienced substantial growth in recent years, driven by the increasing adoption of nuclear medicine procedures, advancements in molecular imaging technologies, and a growing prevalence of chronic diseases. Radiopharmaceuticals are radioactive compounds...

PanGenomic Health Announces Changes to Board of Directors - Vimarsana News

PanGenomic Health Announces Changes to Board of Directors

PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA) announces changes to its board of directors.

Source: yahoo.com